Coya Therapeutics, Inc.COYANASDAQ
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | -99.97% | +103.32% | -95.22% | +0.00% |
| Gross Profit Growth | +0.00% | -144.06% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | -302.14% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | -324.79% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | -330.32% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | -250.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | -250.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +53.01% | +60.93% | +15.65% | +12.14% | +9.93% |
| Weighted Average Shares Diluted Growth | +53.01% | +60.93% | +15.65% | +12.14% | +9.93% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | -131900.61% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | -133454.22% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | -90.26% | +0.00% | +0.00% | +0.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +198.87% | +7.48% | +2.71% | -16.24% | -9.87% |
| Book Value per Share Growth | +107.37% | -30.99% | -10.93% | -28.39% | -22.46% |
| Debt Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| R&D Expense Growth | +39.67% | +7.47% | +64.84% | +80122.98% | +31.16% |
| SG&A Expenses Growth | +12.95% | -10.07% | +11.23% | +139154.23% | +15.22% |